SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.91 CNY | +3.14% |
|
+7.29% | -5.36% |
| Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
| Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
Chart calendar Shenzhen Salubris Pharmaceuticals Co., Ltd.
4722f0d86aa8fdc86.UFoO9lZQK1-CoQor1bsNoSq1XV6IRCA9VQUsHoL62y4.BBI5wjQReTfXlktp499h2GDSHynjAmhoIlFhWdirt2tkGTubMgRFHNSTfQ~e66d982984ccb27c04bcb6b1b59a4df1
Upcoming events on Shenzhen Salubris Pharmaceuticals Co., Ltd.
Past events on Shenzhen Salubris Pharmaceuticals Co., Ltd.
| 2024-04-22 | Q1 2024 Earnings Release |
| 2024-04-22 02:30 am | Annaul General Meeting |
| 2024-03-25 | Q4 2023 Earnings Release |
| 2024-01-08 01:30 am | Extraordinary Shareholders Meeting |
| 2023-12-28 01:30 am | Extraordinary Shareholders Meeting |
| 2023-10-30 | Q3 2023 Earnings Release |
| 2023-08-24 | Q2 2023 Earnings Release |
| 2023-04-18 | Q1 2023 Earnings Release |
| 2023-04-18 02:30 am | Annual General Meeting |
| 2023-03-28 | Q4 2022 Earnings Release |
| 2022-12-12 01:30 am | Extraordinary Shareholders Meeting |
| 2022-10-24 | Q3 2022 Earnings Release |
| 2022-08-09 | Interim 2022 Earnings Release |
| 2022-04-18 | Q1 2022 Earnings Release |
| 2022-04-18 02:30 am | Annual General Meeting |
| 2022-03-28 | FY 2021 Earnings Release |
| 2021-12-17 01:30 am | Extraordinary Shareholders Meeting |
| 2021-10-25 | Q3 2021 Earnings Release |
| 2021-08-23 | Interim 2021 Earnings Release |
| 2021-06-30 02:30 am | Extraordinary Shareholders Meeting |
Past dividends on Shenzhen Salubris Pharmaceuticals Co., Ltd.
| 2023-05-08 | Annual 0.5 CNY |
| 2022-04-26 | Annual 0.4 CNY |
| 2020-05-19 | Annual 0.5 CNY |
| 2019-04-15 | Annual 0.8 CNY |
| 2018-05-03 | Annual 0.8 CNY |
| 2017-05-11 | Annual 0.7 CNY |
| 2016-05-02 | Annual 0.6 CNY |
| 2015-04-23 | Annual 0.7 CNY |
| 2014-05-06 | Annual 0.6 CNY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 4 470 4 661 -4.09% | 2 739 3 282 -16.56% | 3 058 2 941 3.98% | 3 482 3 510 -0.78% | 3 365 3 511 -4.14% | 3 924 |
|
EBITDA Million CNY | Released Forecast Spread | 1 093 1 247 -12.37% | 343 874 -60.76% | 900 818 10.1% | 1 064 803 32.63% | 1 013 995 1.82% | 1 079 |
|
EBIT Million CNY | Released Forecast Spread | 846 1 171 -27.74% | 79,2 425 -81.36% | 586 605 -3.03% | 727 648 12.32% | 656 634 3.44% | 791 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 851 1 122 -24.14% | 56,7 427 -86.71% | 600 600 -0.05% | 714 768 -7.11% | 642 687 -6.62% | 790 |
|
Net income Million CNY | Released Forecast Spread | 715 951 -24.82% | 60,9 571 -89.34% | 534 536 -0.41% | 637 683 -6.69% | 580 599 -3.08% | 687 |
|
EPS CNY | Released Forecast Spread | 0,68 0,91 -25.26% | 0,06 0,55 -89.02% | 0,50 0,50 0% | 0,58 0,60 -3.87% | 0,52 0,54 -2.8% | 0,60 |
| Announcement Date | 28/02/20 | 29/03/21 | 28/03/22 | 28/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS CNY | Released Forecast Spread | 0,22 0,13 69.23% | 0,09 0,42 -78.57% | 0,18 0,15 20% | 0,09 0,11 -18.18% | 0,19 0,20 -5% | 0,11 0,09 22.22% | 0,13 0,14 -7.14% | 0,09 0,11 -18.18% | 0,18 0,18 0% | 0,12 | 0,15 | 0,17 |
| Announcement Date | 18/04/22 | 09/08/22 | 24/10/22 | 28/03/23 | 18/04/23 | 24/08/23 | 30/10/23 | 25/03/24 | 22/04/24 | - | - | - |
More events
Past sector events for Shenzhen Salubris Pharmaceuticals Co., Ltd.
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002294 Stock
- Calendar Shenzhen Salubris Pharmaceuticals Co., Ltd.
